September 10, 2019 | JW Marriott Minneapolis Mall of America | Minneapolis, MN
www.pbmi.com/srx19
In 2021 specialty pharmacy is expected to grow to $500 billion. Specialty drug spend is also expected to reach upwards to 60% of total drug spend. Healthcare stakeholders are not only challenged by the costs and increased utilization of specialty medications, but also by the uncertainty and complexity of specialty pharmacy.
Join PBMI and other healthcare stakeholders for a dynamic and interactive one-day event at PBMI’s 2019 Specialty Rx Forum on September 10, 2019.
The agenda covers a wide variety of topics such as:
- New drugs in the specialty pipeline
- Managing hemophilia
- Cost savings through specialty generics and biosimilars
- Lower net-cost drugs
- Enhancing the patient experience through technology and data devices
- Getting the most out of specialty contracts
- And more.
Early bird rates for this event end July 12, 2019.
Exclusive Offer for Drug Channels readers:
Drug Channels readers can use discount code SRX19 to extend the early bird rate through August 23, 2019! Do you have colleagues who would also like to attend? Feel free to extend this offer to them too.
Click here to register. If you register after July 12th, use discount code SRX19 at checkout to get the early bird rate.
Do you have questions, or are you interested in sponsoring this event? Contact Linda DeChant at ldechant@pbmi.com.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
No comments:
Post a Comment